Hygeia Healthcare (HKG:6078) recorded a decline in attributable profit in 2024 to 598.3 million yuan from 682.9 million yuan in the year-ago period, a Thursday filing with the Hong Kong bourse said.
Earnings per share were 0.95 yuan in the year, down from 1.08 yuan in 2023.
Revenue for the oncology healthcare group rose by 9.1% to 4.45 billion yuan in the year from 4.08 billion yuan a year prior.